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478 BIOMATERIAL GUIDED CARTILAGE REPAIR IN A GOAT
MODEL
B. Sharma1, S. Fermanian1, B. Cascio2, N. Marcus1, J. Elisseeff3.
1Cartilix Inc., Foster City, CA, USA, 2Louisiana State University, New
Orleans, LA, USA, 3Johns Hopkins University, Baltimore, MD, USA
Purpose: Surgical options for cartilage reconstruction may be signiﬁ-
cantly improved through advances in tissue engineering, whereby bioma-
terials are used to facilitate tissue repair. We have developed a cartilage
repair system, named ChonDuxTM, consisting of (1) a photopolymerized
hydrogel that promotes differentiation and cartilage formation by bone
marrow derived stem cells, and (2) a biological adhesive to secure the
hydrogel in a cartilage lesion and integrate newly formed tissue with native
tissue. We hypothesized that ChonDux could be used in conjunction with
marrow stimulation techniques to enhance the environment for cartilage
repair by endogenous stem cells. The goal of this study was to evaluate
the safety and performance of ChonDux in chondral defects in a large
animal model.
Methods: In twenty eight goats, two 6mm diameter defects were created
unilaterally on the right medial femoral condyle. Twenty goats were
treated with ChonDux. Speciﬁcally, the adhesive was applied to the
defect followed by subchondral microdrilling and ﬁlling with the hydrogel.
In eight control goats, the defects were left untreated. Animals were
cast for 2 weeks and sacriﬁced at one (n = 5), six (n = 11), and twelve
months (n = 12) post-surgery. Necropsy was performed to evaluate acute
(1 month) and long term (6 and 12 months) safety. Repair tissue was
analyzed after 6 and 12 months by histology (O’Driscoll score), histomor-
phometry (% defect ﬁll, % GAG), and immunohistochemistry for collagen
types I and II. Mechanical properties of the repair tissue in the ChonDux
group was compared to the contralateral medial condyle.
Results: The ChonDux treated group demonstrated improved cartilage
repair compared to controls after 6 months. Treated defects contained
signiﬁcantly greater ﬁll (78%) and GAG staining (53%) than control
defects (65% ﬁll, 34% GAG). O’Driscoll scores were also greater in the
ChonDux group (17.8) compared to control (14.8), though not statisti-
cally signiﬁcant (p = 0.08). At 12 months, treated defects experienced a
signiﬁcant improvement in % ﬁll (86%) and maintained O’Driscoll scores
compared to the 6 month time point. There was a decrease in % GAG
(34%) from 6 to 12 months, however staining for collagen type II was not
diminished and there was no evidence of cartilage degeneration based
on cell and tissue morphology. The control group showed lower ﬁll (81%),
lower O’Driscoll (15.9) and higher GAG (42%) compared to the treated
group, however statistically signiﬁcant differences between groups were
not found at 12 months. In control groups, histology revealed breaching of
the subchondral bone in many cases which resulted in marrow stimulation
and a variable degree of cartilage repair in this group. The repair tissue
in the ChonDux treated defects demonstrated comparable mechanical
properties to the native tissue and remained stable from 6 to 12 months.
Pathology and histopathology evaluations indicated no local or systemic
adverse responses to the implant in any of the animals.
Conclusions: Overall, this study demonstrated safety and long-term
beneﬁts of ChonDux in conjunction with marrow stimulation in a large
animal model. In particular, % ﬁll and O’Driscoll scores were consistently
higher than the controls and increased or remained stable from 6 to
12 months. Furthermore, mechanical properties were comparable to
native tissue and also remained stable from 6 to 12 months. The use of
biomaterials to guide or enhance the environment for tissue regeneration
may have an impact on clinical approaches for cartilage repair.
479 SPATIOTEMPORAL CONTROL FOR PROLIFERATION
AND DIFFERENTIATION OF BONE MARROW DERIVED
MESENCHYMAL STEM CELLS IN THE REPAIR OF
ARTICULAR CARTILAGE DEFECTS
T. Mimura, S. Imai, K. Nishizawa, K. Mitsuhiko, K. Ando, N. Okumura,
Y. Matsusue. Shiga University of Medical Science, Shiga, JAPAN
Purpose: In the previous study, we revealed that the concentration-
gradient collagen gel effectively recruited the bone marrow-derived mes-
enchymal stem cells (MSCs) to the osteochondral defects in the rabbit
knee via haptotaxis, and enhanced the osteochondral repair (OARSI,
Miami, 2007). In this study, we investigated the effectiveness of timely
administration of bone morphogenetic protein-2 (BMP-2) to the MSCs
which were recruited to the defects by collagen scaffold.
Methods: The concentration-gradient collagen scaffold that we previously
reported were implanted to the full-thickness cartilage defects and recom-
binant human BMP-2 was supplied into the knee joint during one week
by osmotic pumps. Four experimental groups were assigned: BMP-2
was immediately administrated during 1 week after operation (group 1),
BMP-2 was administrated during 1 week from one week postoperatively
(group 2), and BMP-2 was administrated during 1 week from two weeks
postoperatively (group 3), and saline only (control, group 4). Rabbits were
sacriﬁced at 1, 2, 3, 4 and 8 weeks postoperatively, and Bromodeoxyuri-
dine (BrdU) positive cells were enumerated and histological grading score
were counted.
Results: Enumeration of the BrdU positive cells demonstrated that initial
BMP-2 (group 1) increased the number of proliferating cells during
the 1st week, and promoted the differentiation of the proliferating cells
during the 2nd week. The histological score of group 1 was superior as
compared with other groups at the 8 weeks postoperatively.
Conclusions: In combination with the haptotactic recruitment of the
MSCs, timely administration of BMP-2 clearly enhanced the proliferation
and differentiation of the MSCs. This spatiotemporal control of MSC
proliferation and differentiation is warranted to contribute to the successful
regeneration of the full-thickness cartilage defects.
Figure 1. BrdU positive cells at week 1.
Figure 2. BrdU positive cells at week 2.
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CHONDROCYTES TO PARTIALLY RECOVER A HEALTHY
PHENOTYPE IN VITRO AND IN VIVO
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Purpose: Osteoarthritis (OA) is associated with advancing age and/or
traumatic intra-articular injuries. NSAIDs are commonly prescribed to help
reduce pain and improve function, but these drugs do not reverse the
degenerative changes of OA. The administration of compounds such as
glucosamine (GlcN) and chondroitin sulphate (CS) have protective effects
on chondrocytes. Although these compounds enhance extracellular ma-
trix (ECM) production by healthy chondrocytes, it is still unclear what their
effect is on OA chondrocytes.
The aim of this study was to determine whether GlcN has a beneﬁcial
effect on OA chondrocytes when cultured in vitro in 3D hydrogels. The
inﬂammatory response and ECM formation capacity of OA chondrocytes
were investigated with varying GlcN concentration. An in vivo OA model
was developed in rats to detect degenerative changes at 4 and 8 weeks.
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GlcN was administered alone or in combination with a CS-based gel
by a weekly intra-articular injection for 3 weeks. ECM organization was
assessed by histology.
Methods: Healthy and OA chondrocytes were isolated from the tibial
plateaus of human cadaveric articular cartilage, or from patients under-
going knee arthroplasty (NDRI, Philadelphia, USA). Cells were cultured
in chondrocyte medium (CM) for 2 passages, then photopolymerized
into 10% w/v PEGDA or 15% w/v PEGDA-RGD modiﬁed hydrogels.
Constructs were cultured for 1, 7, and 28 days in CM supplemented
with 0, 0.1, 1, and 2mM GlcN, or in chondrogenic medium (CM+) with
2mM GlcN. Cell viability was assessed by live-dead and DNA assays,
while tissue formation by histology, GAG, and collagen assays. Gene
analysis was performed by PCR. For in vivo studies, OA was induced
in rats by mechanical destabilization of the medial meniscus. Articular
cartilage changes were evaluated after 4 and 8 weeks to validate the
model. Two mM GlcN solutions in phosphate buffer saline (PBS) or in
CSMA-aldehyde gels were intra-articularly injected weekly for 3 weeks.
PBS was injected in control joints. Aggrecan synthesis was chosen as a
parameter to evaluate ECM regeneration and assessed by histology.
Results: OA cells were more susceptible to hydrogel encapsulation and
culture than healthy chondrocytes, as shown by viability data. RGD
motifs decreased cell mortality. Although donor dependent, histology and
GAG assays showed trends of increasing ECM formation with increasing
GlcN concentration. CM+ revealed a further chondrogenic enhancement
as compared to CM. PCR conﬁrmed the same trend for ECM related
markers. The inﬂammatory response (Il-1b and TNF-a) of OA cells
encapsulated in PEGDA decreased with increasing culturing time, while
it increased with increasing GlcN concentration. Conversely, the anti-
inﬂammatory response (Il-4) increased with increasing culture time and
GlcN concentration. RGD motifs induced an upregulation of Il-1b and
Il-4 over time and a downregulation with increasing GlcN concentration.
TNF-a did not signiﬁcantly change. Similar conclusions could be drawn
for healthy chondrocytes, with the exception of an upregulation of Il-4 with
increasing GlcN concentration.
From histological analysis, GlcN alone or in combination with CSMA-
aldehyde gel induced a signiﬁcant slow down of arthritic damage and
initial repair in rats that developed mild OA. Partial or minimal slow down
of OA and repair was induced at a late OA stage.
Conclusions: GlcN administration to OA chondrocytes enhanced cellular
ECM formation and modulated the inﬂammatory and anti-inﬂammatory re-
sponses in vitro. GlcN and GlcN-CSMA administrations initiated cartilage
regeneration in OA rats in vivo. GlcN could be a potential factor for mild
OA treatments and for the regeneration of cartilage in tissue engineering
applications.
481 IN-ADVANCE TRANS-MEDULLARY STIMULATION OF
MESENCHYMAL STEM CELLS ENHANCES SPONTANEOUS
REPAIR OF FULL-THICKNESS ARTICULAR CARTILAGE
DEFECTS
K. Nishizawa, S. Imai, T. Mimura, M. Kubo, Y. Matsusue. Shiga
University of Medical Science, Otsu, JAPAN
Purpose: Mesenchymal stem cells (MSCs) have the potential to dif-
ferentiate into cartilage, suggesting that the MSCs, especially those
close to the cartilage defects, are an important cell source for cartilage
regeneration. In the present study, we stimulated MSCs to differentiate
into the chondorcyte progenitors via trans-medullary approach using the
rabbit knees. Following the trans-medullary stimulation of MSCs, full-
thickness cartilage defects were created in order to investigate whether
the chondorcyte progenitors stimulated thereby could enhance the repair
of the full-thickness cartilage defects.
Methods: The animals were divided into 3 groups: In Group 1, full-
thickness articular cartilage defects (5mm in diameters; 5mm in depth)
were created in the patella groove of the femur. This group served as the
negative control. In Group 2, trans-medullary holes (2.5mm in diameter)
reaching to the immediate vicinity of the subchondral bone were created
4 days prior to the creation of cartilage defects. In Group 3, bFGF was
administered through the trans-medullary holes in order to augment the
stimulation of the MSCs. Other procedures followed those of the group 2.
The rabbits were sacriﬁced at 1, 2, 3, 4 and 8 weeks after the creation of
the osteochondral defects, and Bromodeoxyuridine (BrdU) positive cells
were enumerated and the histological grading score was counted.
Results: Enumerated BrdU positive cells indicated proliferation of the
cells was signiﬁcantly enhanced in Group 2 and 3 as compared with in
that of Group 1. The histological grading score of in Group 3 was superior
to the other groups and the score of the Group 1 remained the worst
throughout the studied periods.
Conclusions:We demonstrated that the in-advance stimulation of MSCs
via trans-medullary approach effectively increased the population of chon-
drocyte progenitors. The chondorcyte progenitors stimulated thereby are
likely to be recruited to the osteochondral defects at the appropriate time,
contributing to the repair of full-thickness articular cartilage defects.
482 ENDOCHONDRAL OSSIFICATION: AN ALTERNATIVE
APPROACH FOR BONE REPAIR?
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1Erasmus MC, Rotterdam, NETHERLANDS, 2Royal college of surgeons,
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Purpose: Bioengineered cell constructs can be used in the treatment
of bone defects. Often Bone Marrow Stromal Cells (BMSCs) are used
that are in-vitro stimulated towards the osteogenic lineage aiming at
intramembranous bone formation. The success of this approach is disap-
pointing. A major concern in these constructs is core degradation, which
is caused by a lack of blood supply. We hypothesize that stimulation
of cells towards the endochondral ossiﬁcation process would be more
successful. In this study we test how in-vitro priming of human BMSCs
inﬂuences the endochondral ossiﬁcation process.
Methods: In vivo implantation: hBMSCs were seeded in collagen-
GAG scaffolds (3.0×105 per 8mm2). Seeded scaffolds were cultured
for 21 days on chondrogenic medium (n = 5) (DMEM-LG, TGF-beta2
10 ng/ml, Dexamethasone (Dex) 10−7 M, Ascorbic acid 25mg/ml, ITS) or
osteogenic medium (n = 4) (DMEM-HG, 10% FCS, Dex 10−7 M, Beta-
Glycerol-Phosphate (BGP) 10mM, Ascorbic acid 0.1mM) before they
were subcutaneously implanted at the back in nude mice. After 28 days
the scaffolds were obtained. Immunohistochemistry for Col-2 and Col-
10 and Von Kossa/Thionin staining, to observe mineralization and gly-
cosaminoglycan production, were performed.
In vitro pellet cultures: hBMSCs of three donors were obtained during
hip arthroplasty. 2.0 105 cells were cultured in pellets in 0.5ml of chon-
drogenic medium (as above). After 21 days of culture, when cartilage
was formed, the cultures were divided in three groups to be cultured for
another 14 days: group1 remained on chondrogenic medium; group 2
remained on chondrogenic medium and had BGP (10mM) added to
allow mineralization; in group 3 TGF-beta was removed from the medium,
BGP (10mM) was added and Dex was reduced to 10−8 M (osteogenic
medium). At day 7, 14, 21, 35 immunohistochemistry for Col-2 and Col-10
and Von Kossa/Thionin staining were performed. On the culture medium
of day 14, 21, 35 VEGFa production was determined by ELISA and gelatin
zymography for MMP-production was performed. For each analysis 3
pellets were used. All outcome measures were statistically evaluated
using mixed model analysis.
Results: In vivo implantation: Scaffolds that were pre-cultured on chon-
drogenic medium showed Col-2 and Col-10 production, but no miner-
alization. Moreover, vessels ingrowth that contained erythrocytes were
present. Pre-culturing with osteogenic medium induced mineralization,
but pycnotic cell nuclei were present and no Col-10 or vessel ingrowth
were observed.
In vitro pellet cultures: Pellets cultured in chondrogenic medium showed
progressive production of Col-2 and Col-10. In the medium of these
chondrogenic cultured pellets VEGF and MMPs were evidently present
at day 14, 21, 35. When pellets were switched to culture medium con-
taining BGP, independent of the presence of TGF-beta, huge regions of
mineralization were found. In the medium of these switched conditions
VEGF and MMP productions had severely diminished.
Conclusions: We demonstrated that in vivo implantation of in vitro
chondrogenically primed hBMSCs results in vessel invasion and Col-10
production, but not mineralization. By showing that VEGF and MMPs were
produced in chondrogenically differentiated hBMSCs we demonstrated
that these cells produce anabolic and catabolic factors that are known
to be important for the conversion of an avascularized to a vascularized
matrix. Inducing mineralization in this endochondral process does, how-
ever severely diminish these capacities. Altogether these results suggest
that chondrogenical priming of hBMSCs may improve vessel invasion in
bioengineered constructs, thereby optimizing its capacity to repair bone
defects.
